Clinical Trial Results:
A Phase III, Randomized, Controlled, Observer-Blind, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity of a Single Intramuscular Dose of Three Lots of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture or of a Trivalent Subunit Influenza Vaccine Produced in Embryonated Hen Eggs, in Healthy Adults Subjects Aged 18 to < 61 years
Summary
|
|
EudraCT number |
2005-002257-47 |
Trial protocol |
LT |
Global completion date |
08 Apr 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Feb 2016
|
First version publication date |
20 Feb 2016
|
Other versions |
|
Summary report(s) |
V58P9_Ctgov |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.